scholarly journals A phase 1 trial of SGN‐CD70A in patients with CD70‐positive, metastatic renal cell carcinoma

Cancer ◽  
2019 ◽  
Vol 125 (7) ◽  
pp. 1124-1132 ◽  
Author(s):  
Sumanta K. Pal ◽  
Andres Forero‐Torres ◽  
John A. Thompson ◽  
John C. Morris ◽  
Saurabh Chhabra ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase 1 ◽  
Phase 1 Trial

scholarly journals Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma

Cancer ◽  
2011 ◽  
Vol 118 (7) ◽  
pp. 1868-1876 ◽  
Author(s):  
Ana M. Molina ◽  
Darren R. Feldman ◽  
Martin H. Voss ◽  
Michelle S. Ginsberg ◽  
Michael S. Baum ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase 1 ◽  
Phase 1 Trial

scholarly journals Phase 1 Trial of Allogeneic Gene-Modified Tumor Cell Vaccine RCC-26/CD80/IL-2 in Patients with Metastatic Renal Cell Carcinoma

2010 ◽  
Vol 21 (3) ◽  
pp. 285-297 ◽  
Author(s):  
Alexander Buchner ◽  
Heike Pohla ◽  
Gerald Willimsky ◽  
Bernhard Frankenberger ◽  
Ronald Frank ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Tumor Cell ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase 1 ◽  
Cell Vaccine ◽  
Tumor Cell Vaccine ◽  
Phase 1 Trial

P0125 A phase 1/2 trial of BNC105P with everolimus in metastatic renal cell carcinoma

2015 ◽  
Vol 51 ◽  
pp. e26
Author(s):  
S. Pal ◽  
A. Azad ◽  
S. Bhatia ◽  
H. Drabkin ◽  
B. Costello ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase 1

scholarly journals Lenvatinib in combination with everolimus in patients with advanced or metastatic renal cell carcinoma: A phase 1 study

2018 ◽  
Vol 25 (11) ◽  
pp. 922-928 ◽  
Author(s):  
Nobuaki Matsubara ◽  
Yoichi Naito ◽  
Kenji Nakano ◽  
Yutaka Fujiwara ◽  
Hiroki Ikezawa ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase 1 ◽  
Phase 1 Study

scholarly journals Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma

2018 ◽  
Vol 68 (2) ◽  
pp. 319-329 ◽  
Author(s):  
Charlotte M. Huijts ◽  
◽  
Inge M. Werter ◽  
Sinéad M. Lougheed ◽  
Ruben S. Goedegebuure ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Low Dose ◽  
Phase 1 ◽  
Oral Cyclophosphamide ◽  
Phase 1 Study ◽  
Dose Oral

Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma

Cancer ◽  
2010 ◽  
Vol 117 (4) ◽  
pp. 758-767 ◽  
Author(s):  
Brian I. Rini ◽  
Mark Stein ◽  
Pat Shannon ◽  
Simantini Eddy ◽  
Allison Tyler ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Dose Escalation ◽  
Renal Cell ◽  
Phase 1
Sign in / Sign up

Export Citation Format

Share Document